NCI Cancer Bulletin for January 24, 2012

January 24, 2012 • Volume 9 / Number 2 Read the NCI Cancer Bulletin The latest issue of the NCI Cancer Bulletin is now available at http://www.cancer.gov/ncicancerbulletin. Keep up to date on the latest research and advances in the prevention, treatment, and understanding of cancer. News Read This Issue Featured Article: Genetic Abnormality Predicts Treatment Benefit for Patients with Rare Brain Tumor » Ovarian Cancer Patients with BRCA Mutations May Fare Better than Non-Carriers » Experimental Drug Improves Survival in Previously Treated Metastatic Colorectal Cancer » Differences in Estrogen Metabolism May Influence Breast Cancer Risk » Epigenetic Study Suggests Possible Treatment for Retinoblastoma » Also in the Journals: Before Breast Cancer Surgery, Two Anti-HER2 Drugs May Be Better than One »   Commentary Read This Issue A Conversation with the NCI Women Scientist Advisors » In Depth Read This Issue More than a Game: Super Bowl Initiative Helps Scientists Study the "Normal" Breast » Staying Alive: New Technique Grows Normal and Cancer Cells Rapidly » Targeted Therapies Offer Treatment Options for Advanced Kidney Cancer » Featured Clinical Trial: First-in-Humans Study of New Immunotherapy Agent » Updates Read This Issue FDA Update » Notes » Do you know someone who would enjoy receiving the NCI Cancer Bulletin? To send a copy of the latest issue to a colleague, visit www.cancer.gov/ncicancerbulletin. The NCI Cancer Bulletin will be sent to you biweekly unless you unsubscribe. To unsubscribe, send a blank email to nci-bulletin-signoff-request@list.nih.gov.